Evan Wu, MD, PhD
Core Clinical Member, Translational and Clinical Research, University of Hawaiʻi Cancer Center
Academic Appointment(s):
Assistant Professor (Assistant Researcher), University of Hawaiʻi Cancer Center, University of Hawaiʻi at Mānoa
Degree(s):
PhD, Biostatistics, Johns Hopkins
MD, University of Miami
MS, Biostatics, University of Pennsylvania
Medical Oncology Fellowship, Johns Hopkins
Internal Medicine Residency, Baylor College of Medicine/MD Anderson
Research Focus
Thoracic Oncology
Selected Publications
Wu ES, Park JY, Zeitouni JA, Gomez CR, Reis IM, Zhao W, Kwon D, Lee E, Nelson OL, Lin HY, Franzmann EJ, Savell J, McCaffrey TV, Goodwin WJ, Hu JJ. (2016). Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis. Head Neck. Aug;38(8):1234-41.
Alkhatib HH, Maroun CA, Amin N, Zhu G, Guller M, Wu E, Mandal R. (2022). Tumor Histological Grade and Immunotherapy Response in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg, 148(6), 540-546. doi:10.1001/jamaoto.2022.0640.
Guller M, Herberg M, Amin N, Alkhatib H, Maroun C, Wu E, . . . Mandal R. (2021). Nutritional Status as a Predictive Biomarker for Immunotherapy Outcomes in Advanced Head and Neck Cancer. Cancers (Basel), 13(22). doi:10.3390/cancers13225772.
Wu ES, & Srour SA. (2017). Paraneoplastic Hyperleukocytosis in Pancreatic Adenocarcinoma. J Pancreat Cancer, 3(1), 84-86. doi:10.1089/pancan.2017.0019.
